Abstract
In 1942 the uncertainty about the enzymatic character of renin promoted investigations to establish whether typical proteolytic enzymes, such as those elaborated by digestive glands, could reproduce the action of renin upon the same blood substrates. The first experiments [Croxatto and Croxatto, 1941 (2)] not only showed that pepsin reproduced the typical action of renin, giving rise to a peptide similar to angiotensin, but also opened a new exploratory technique that strengthened the view that blood proteins are a rich potential source of vasoactive peptides. In fact, the well-known proteolytic enzymes of the digestive tract can produce vasoactive peptides similar or identical to those released by endogenous enzymatic systems (renin, kallikrein). However, the activity of the latter enzymes is far more restricted. Renin acts exclusively upon renin-substrate or its synthetic homologue, but it does not liberate kinins from kininogens and, in contrast, plasma kallikreins are unable to produce angiotensin from blood substrates. On the other hand, endopeptidases such as pepsin, trypsin and chymotrypsin can hydrolyze both renin-substrate and kininogen. In the terminal products of the hydrolyzate, it is possible to characterize angiotensin- and bradykinin-like peptides among the other pharmacologically active substances which are less known.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alonso, O., Croxatto, R., Croxatto, H. R.: A comparative study of pepsitensin and hypertensin. Proc. Soc. exp. Biol. (N. Y.) 52, 61 (1943).
Arneil, G. C., Dekanski, J. B.: Excess of vasopressor activity in plasma of nephritic children with hypertension. Lancet 1954II, 1204.
Blair, A. M. J. N.: Pharmacological actions of pepsitensin. Brit. J. Pharmacol. 18, 255 (1962).
Bohr, D. F., Johansson, B.: Contraction of vascular smooth muscle. Comparison with response to known vasoactive agents. Circulat. Res. 19, 593 (1966).
Bohr, D. F., Sobiezki, J.: An unidentified plasma component that causes constriction of perfused vascular bed. Fed. Proc. 27, 1396 (1968).
Braun-Menendez, E., Fasciolo, J. C., Leloir, L. F., Muñoz, J. M., Taquini, C.: Relacionesentre hipertensina y pepsitensina. Rev. Soc. argent. Biol. 19, 304 (1943).
Braun-Menendez, E., Paladini, A. C.: Pressor polypeptides formed in vivo and in vitro as mediators of renal hypertension. Circulation 17, 668 (1958).
Burn, D. H.: Estimation of the antidiuretic potency of pituitary (posterior lobe) extract. Quart. J. Pharmacol. 4, 517 (1931).
Cabrera, R. R., Nolly, H. L., Fasciolo, J. C.: Acción de la quimotripsina sobre plasmas de diferentes especies. Resúmenes de Comunicaciones de la XVI reunión de la Soc. Argentina de Investigación Clinica 1, 71 (1971).
Croxatto, H. B.: Estudio de la anefrotensina en la sangre humana. Tesis de Grado, Facultad de Medicina, Universidad Católica de Chile (1961).
Croxatto, H. R.: La acción hipertensinásica. Inactivación de la hipertensina y de los principios presor y acitócico de la posthipófisis en el organismo. Rev. Med. Aliment (Santiago) 5, 259 (1943).
Croxatto, H. R.: Active polypeptides formed by pepsin. In: Polypeptides which stimulate plain muscle (Gaddum, J. H., Ed.). Edinburgh-London: Livingstone 1955.
Croxatto, H. R.: Polypeptides with posterior pituitary-like activities. London: Butterworth 1956.
Croxatto, H. R.: Polypeptides with posterior pituitary-like activities. In: The Neurohypophysis 51 (1957) (Heller, H., Ed.). Colston Papers 8.
Croxatto, H. R.: Active polypeptides obtained from the blood and arterial hypertension. In: Perspectives in Biology (Cori, C. F., Foglia, V. G., Leloir, L. F., Ochoa, S., Eds.). Amsterdam: Elsevier Publishing 1963.
Croxatto, H. R.: Polipéptidos vasoactivos derivados de substratos sanguíneos. Ann. 1st Superiore di Sanità (Rome) 2, 575 (1966).
Croxatto, H. R., Andrade, F., BARNAFI, L.: (1) Acción antidiurética de plasma y suero sanguineos. Bol. Soc. Biol. (Santiago) 10, 5 (1953).
Croxatto, H. R., Barnafi, L.: (3) Antidiuretic substances of the blood. Nature (Lond.) 172, 304 (1953).
Croxatto, H. R., Barnafi, L.: (1) Hormone and hormone-like activity of active polypeptides. Recent Prog. Hormone Res. 16, 263 (1960).
Croxatto, H. R., Barnafi, L., Ferrer, R.: (2) The antidiuretic potency of pregnant women serum. Acta Physiol, latamer. 4, 166 (1954).
Croxatto, H. R., Barnafi, L., Rojas, G., Reyes, A., Infante, A.: (2) Antidiuretic and oxytocic substances liberated by the digestion of plasmatic proteins with pepsin. Nature (Lond.) 171, 82 (1953).
Croxatto, H. R., Barnafi, L., Villalobos, S.: (1) Influencia de la renina en la reacción hipertensinógeno-pepsina y liberación de un principio antidiurético. Bol. Soc. Biol. (Santiago) 9, 47 (1954).
Croxatto, H. R., Belmar, J.: Hypertensive effects of bradykinin in rats. Nature (Lond.) 192, 879 (1961).
Croxatto, H. R., Belmar, J., Pereda, T., Labarca, E.: Hypertensive effects of bradykinin and anephrotensin in normal and nephrectomized animals. Acta Physiol, lat.-amer. 12, 19 (1962).
Croxatto, H. R., Croxatto, R.: (1) Inhibitory action of amino-oxydase and tyrosinase upon the vasoconstrictor effect of hypertensin. Proc. Soc. exp. Biol. (N. Y.) 48, 392 (1941).
Croxatto, H. R., Croxatto, R.: (2) Naturaleza química de la hipertensina. Rev. Soc. argent. Biol. 17, 439 (1941).
Croxatto, H. R., Croxatto, R.: (3) Rev. Méd. Chile 59, 793 (1941).
Croxatto, H. R., Croxatto, R.: Pepsitensin — A hypertensin-like substance produced by peptic digestion of proteins. Science 95, 101 (1942).
Croxatto, H. R., Croxatto, R., Manriqtjez, H., Valenzijela, B.: Destrucción de la hipertensina y de la pepsitensina por la aminopeptidasa. Boi. Soc. Biol. (Santiago) 1, 137 (1942).
Croxatto, H. R., Croxatto, R., Rioseco, M.: Acción de la carboxipeptidasa sobre la pepsitensina, vasopresina y ocitocina. Rev. Soc. argent. Biol. 21, 23 (1945).
Croxatto, H. R., Crtjzatt, H.: Ineffectiveness of carboxypeptidase B in inhibiting the pressor effect of incubated human plasma. Experientia (Basel) 25, 59 (1969).
Croxatto, H. R., Diaz, G.: Adrenergic receptor blockers on pressor activity of incubated human plasma. Proc. Soc. exp. Biol. (N. Y.) 130, 465 (1969).
Croxatto, H. R., Labarca, E.: Vasopressor polypeptide (anephrotensin) obtained from the serum of the amphibian Calyptocephalella gayi. Acta Physiol, lat.-amer. 12, 251 (1962).
Croxatto, H. R., Marsano, A., Croxatto, R.: Acción hipertensinogena y coagulante de venenos de serpientes. An. Soc. Biol. Bogota 1, 147 (1944).
Croxatto, H. R., Pereda, T., Belmar, J., Labarca, E.: Polypeptides formed by acidification of blood serum. Ann. N. Y. Acad. Sci. 104, 146 (1963).
Croxatto, H. R., Pereda, T., Mellado, R.: Peptides with oxytocic and pressor activity obtained from acidified serum. Nature (Lond.) 184, 1496 (1959).
Croxatto, H. R., Pereda, T., Mellado, R., Zamorano, B.: (2) Anefrotensina un nuevo péptido de acción vascular. En: Péptidos activos (Croxatto, H., Ed.). Santiago: Centro de Publicaciones Biológicas, Universidad de Chile 1960.
Croxatto, H. R., Pereda, T., Zamorano, B.: Oxytocic substances in blood serum. In: Oxytocin (Caldeyro Barcia, R., Heller, H., Eds.). Oxford: Pergamon Press 1961.
Croxatto, H. R., Reyes, A., Barnafi, L.: (4) Características del principio antidiurético liberado del suero sanguineo por la acción de la pepsina. Bol. Soc. Biol. (Santiago) 7, 1 (1953).
Croxatto, H. R., Rioseco, M.: Hipertensinasa de glóbulos rojos y pepsitensina. Bol. Soc. Biol. (Santiago) 4, 1 (1947).
Croxatto, H. R., Roblero, J.: Enzymatic system and the formation of a vasopressor albumin in the incubated plasma. In: Bradykinin and related kinins: cardiovascular, biochemical and neural actions (Sicuteri, F., Rocha De Silva, M., Beck, N., Eds.). New York: Plenum Press 1970.
Croxatto, H. R., Roblero, J., Ossio, M.: Substancias vasopresoras formadas en el suero sanguíneo por incubación a 38 °C a pH normal. Arch. Biol. Med. exp. 2, 55 (1965).
Croxatto, H. R., Rojas, G., Barnafi, L.: Acciones ocitocica y presora separables de la pepsitensina. Bol. Soc. Biol. (Santiago) 8, 84 (1950).
Croxatto, H. R., Rojas, G., Barnafi, L.: (1) An antidiuretic substance obtained by digestion of globulin with pepsin. Science 113, 494 (1951).
Croxatto, H. R., Rojas, G., Barnafi, L.: (2) The liberation of an antidiuretic factor by the hypertensinogen-pepsin reaction. Acta Physiol, lat.-amer. 2, 178 (1951).
Croxatto, H. R., Vera, R., Roblero, J., Belmar, J.: Polypeptides formed by acidification of blood serum of normal and hypertensive rats. Canad. med. Ass. J. 90, 313 (1964).
Dengler, H.: Untersuchungen über Pepsitensin. Z. ges. exp. Med. 41, 378 (1956).
Elliot, D. F., Peart, W. S.: Aminoacid sequence in hypertensin. Nature (Lond.) 177, 527 (1956).
Franze De Fernandez, M. T., Paladini, A. C., Delius, A. E.: Isolation and identification of a pepsitensin. Biochem. J. 97, 540 (1965).
Gordon, D. B., Rieske, C. L.: Arneil factor: a pressor substance, probably a protein, in incubated plasma. Fed. Proc. 26, 368 (1967).
Greenbaum, L. M., Yamafuji, K., Hosoda, T.: Studies on the peptic degradation of bovine bradykininogen. Biochem. Pharmacol. 14, 411 (1965).
Grollman, A., Ebihara, A.: Comparison of the pressor activity and the renin content of the renal venous effluent in patients suspected of suffering surgically remediable hypertension. Texas Rep. Biol. Med. 26, 313 (1968).
Grollman, A., Krishnamurty, V. S. R.: A new pressor agent of renal origin; its differentiation from renin and angiotensin. Amer. J. Physiol. 221, 1499 (1971).
Habermann, E.: Strukturaufklärung kininliefernder Peptide aus Rinderserumkininogen. Naunyn-Schmiedebergs Arch. Pharmak. exp. Path. 253, 474 (1966).
Habermann, E., Blennemann, G., Müller, B.: Charakterisierung und Reinigung peptischer kininliefernder Fragmente (PKF) sowie von “Pepsitocin” aus Rinderserum-Kininogen. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 253, 444 (1966).
Habermann, E., Müller, B.: Zur enzymatischen Spaltung peptischer kininliefernder Fragmente (PKF) sowie von Rinderserum-Kininogen. Naunyn-Schmiedebergs Arch. Pharmak. exp. Path. 253, 464 (1966).
Habermann, E., Schuck, S.: Einige Beziehungen zwischen Pepsitocin und Plasmakininen. Naturwissenschaften 51, 61 (1964).
Hadju, S., Leonard, E.: A serum protein system affecting contractility of the frog heart present in increased amounts in patients with essential hypertension. Circulat. Res. 6, 740 (1958).
Hadju, S., Weiss, H., Titus, E.: The isolation of cardio-active principle from mammalian tissue. J. Pharmacol, exp. Ther. 120, 99 (1957).
Heller, H.: Antidiuretic substances. J. Pharm. Pharmacol. 3, 609 (1951).
Helmer, O. M., Page, I. H.: Formation of angiotensin-like pressor substance from action of crystalline pepsin on renin-activator. Proc. Soc. exp. Biol. (N. Y.) 49, 389 (1942).
Hochstrasser, K., Bachhuber, F., Werle, E.: Zur Frage der Identität von Pepsitensin. Hoppe-Seylers Z. physiol. Chem. 350, 1225 (1969).
Horton, E. W.: The estimation of urinary kallikrein. J. Physiol. (Lond.) 148, 267 (1959).
Huggins, C. G., Pavesi, G., Arias, L.: The enzymatic formation of the vasopressor polypeptide substance A by a crystalline enzyme of Bacillus subtilis. Biochem. Pharmacol. 13, 697 (1964).
Huggins, C. G., Thampi, S. N.: Vasopressor principle liberated by a crystalline enzyme of “Bacillus subtilis” (Nagarse) from heart treated plasma. In: International Symposium of vasoactive polypeptides: bradykinin and related kinins (Rocha E Silva, M., Rothschild, H. A., Eds.). Sao Paulo (Brasil): 1967.
Huggins, C. G., Walaszek, E. J.: Formation of a pharmacologically active substance from plasma proteins. Proc. Soc. exp. Biol. (N. Y.) 100, 100 (1959).
Hyssel, J. W., Bohr, D. F.: Renal vascular response to plasma and to known vasoactive substances. Proc. Soc. exp. Biol. (N. Y.) 135, 930 (1970).
Jeffers, W. A., Livezey, M. M., Austin, J. H.: A method for demonstrating an antidiuretic action of minute amounts of Pitressin: statistical analysis of results. Proc. Soc. exp. Biol. (N. Y.) 50, 184 (1942).
Kenner, Th., Waldhäusl, W.: A non-dialysable, heat-stable hypertensive substance in the serum of rats. Nature (Lond.) 204, 581 (1964).
Kenner, T., Waldhätjsl, W.: Zur biologischen Bedeutung des nach mehrstündiger Erwärmung in Serum und Plasma nachweisbaren pressorischen Prinzips. Z. Kreisl.-Forsch. 54, 1143 (1965).
Khatrallah, PH. A., Page, I. H.: Vasopressor lipid to incubated plasma. Amer. J. Physiol. 199, 341 (1960).
Lavras, A. A. C., Fichman, M., Hirsichi, E., Schmutziger, P., Tobo, T., Boucatjlt, M. A.: Acao da Quimotripsina sobre o plasma de Bothrops jararaca. Acta Cientifica Venezolana. X Congreso Latinoamericano de Ciencias Fisiológicas 22, 39 (1971).
Leloir, L. F., Muñoz, J. M., Braun-Menendez, E., Fasciolo, J. C.: La secreción de renina y formación de hipertensina. Rev. Soc. argent. Biol. 16, 75 (1940).
Lowe, T. E., Nayler, W. G.: Kinekard: A blood-plasma fraction with notable cardiovascular activity. Lancet 1965 II, 218.
Luduena, F. P.: Acción de los preparados de hipertensina sobre los músculos lisos. Rev. Soc. argent. Biol. 16, 358 (1940).
Masson, G. M. C., Helmcke, G., Corcoran, A. C., Page, I. H.: Pressor and myotrophic activities of incubated plasma. Proc. Soc. exp. Biol. (N. Y.) 94, 544 (1957).
Mcglory, D. H., Olsen, S., Field, L.: A pressor material produced by the action of pepsin and casein. J. biol. Chem. 219, 299 (1956).
Nayler, W. G., Mccullogh, M.: The action of anions on cardiac muscle. Australian J. exp. Biol. med. Sci. 38, 117 (1960).
Nayler, W. G., Race, D., Price, J. M., Lowe, T. E.: Some effects of a cardioactive fraction isolated from human blood plasma on the peripheral circulation of the dog. Circulat. Res. 18, 1 (1966).
Nayler, W. G., Robertson, P. G. C., Price, J. M., Lowe, T. E.: Some properties of a cardioactive substance isolated from human plasma. Circulat. Res. 16, 553 (1965).
Nolly, H. L., Cabrera, R. R., Fasciolo, J. C.: Formación en plasma humano de una substancia presora angiotensin-like Formación en plasma humano de una substancia presora angiotensin-like “in vitro”. Resúmenesde Comin vitro. Resúmenes de Com. de la XVI Reunión de la Soc. Argentina de Invest. Clin. (1971).
Page, I. H.: Circulatory system: Hypertension, experimental compression capsules. In: Medical Physics, Vol. 2. Chicago: The Year Book Publishers 1950.
Page, I. H., Bumpus, F. M.: A new hormone, angiotensin. Clin. Phar. exp. Ther. 3, 758 (1962).
Page, I. H., Helmer, O. M.: Angiotonin-activator, renin and angiotonin-inhibitor, and the mechanism of angi-tonin tachyphylaxis in normal, hypertensive and nephrectomized animals. J. exp. Med. 71, 495 (1940).
Patva, A. C. M.: (1) Estudio comparativo entre a pepsitensina e a hipertensina. Tese, Scola Paulista de Medicina, Sao Paulo, Brasil (1954).
Patva, A. C. M., Bandiera, T., Prado, J. L.: (2) Nonidentity between pepsitensin and hyper- tensin revealed by paper electrophoresis. Science 120, 611 (1954).
Peterlik, M., Waldhäusl, W.: Isolation of a non-dialysable active vasopressor peptide from pig serum. Nature (Lond.) 214, 279 (1967).
Plentl, A. A., Page, I. H.: The action of crystalline proteolytic enzymes on angiotensin. J. exp. Med. 79, 205 (1944).
Prado, J. L., Prado, E. S., Jurkiewics, A.: Crystalline bacterial proteinase from B. subtilis (Nagarse) as a new kininogenase. Arch. int. Pharmacodyn. 147, 53 (1964).
Reyes, A.: Características del principio antidiurético liberado del suero sanguíneo por la acción de la pepsina. Tesis de Grado, Facultad de Medicina, Universidad de Chile (1952).
Rioseco, M.: Nueva contribución al estudio de la pepsitensina. Tesis de Grado, Facultad de Medicina, Universidad de Chile (1945).
Roblero, J.: Estudio comparativo entre ocitócina y el principio ocitocico obtenido por la digestión del suero humano. Tesis de Grado, Facultad de Filosofía y Educación, Universidad Católica de Chile (1956).
Roblero, J., Croxatto, H. R.: Vasoactive substances formed in blood serum by incubation at 37 °C at normal pH. International Symposium on vasoactive polypeptides: bradykinin and related kinins (Rocha E Silva, M., Rotschild, H. A., Eds.). Sao Paulo: Brasil 1967.
Roblero, J., Croxatto, H. R.: Vasoactive substances formed in blood serum by incubation. N. Y. St. J. Med. 15, 235 (1968).
Rocha E Silva, M.: Bradykinin, its occurrence and physiological significance. XXI International Congress of Physiological Sciences, Buenos Aires. 1, 50 (1959).
Rocha E Silva, M.: Biochemistry and Pharmacology of bradykinin. In: Polypeptides which affect smooth muscles and blood vessels. Oxford: Pergamon Press 1960.
Rosas, R.: Anefrotensina en ratas tratadas con DCA. In: Peptidos Activos (Croxatto, H., Ed.). Santiago: Universidad de Chile 1960.
Rosas, R.: Vasoactive peptides and substrates and their relation to protein handling by the kidney. Circulat. Res. 12, 573 (1963).
Rosas, R., Croxatto, H. R.: Vasoactive substance in blood and urine of DCA hypertensive rats. Circulat. Res. 10, 880 (1962).
Rosas, R., Miyata, T., Hoobler, S. W., Bohr, D. F.: Peptides in urine of DCA-treated and Figure-og-8 rats. Proc. Soc. exp. Biol. (N. Y.) 118, 456 (1963).
Rosas, R., Montague, D., Groes, M., Bohr, F. D.: Cardiac action of vasoactive polypeptides in the rat. I. Bradykinin. Circulat. Res. 16, 150 (1965).
Schweikert, J. R., Carey, R. M., Liddle, G. W.: Evidence that the “renal pressor substance” of Grollman is related to angiotensin I. Clin. Res. 19, 32 (1971).
Tsuru, D., Mcconn, J. D., Yasunobu, K. T.: Bacillus subtilis neutral proteinase. II. Some physicochemical properties. J. biol. Chem. 240, 2415 (1965).
Tuppy, H.: Natürliche oxytocische Substanzen. Naunyn-Schmiedebergs Arch. Pharmak. Exp. Path. 228, 94 (1956).
Tuppy, H.: Biochemical studies on oxytocinase. In: Oxytocin (Caldeyro-Barcia, R., Heller, H., Eds.). Oxford: Pergamon Press 1961.
Turba, F., Hetzel, H.: Über ein oxytocisch wirkendes Peptid aus Serumprotein. Biochem. Z. 325, 524 (1954)
Venezian, S.: Polipeptidos activos derivados del hipertensinögeno purificado. Tesis de Grado, Facultad de Medicina, Universidad Catolica de Chile (1955).
Walaszek, E. J., Huggins, C. G.: Substance A: A hypertensive polypeptide from fraction IV-4 plasma protein. J. Pharmacol, exp. Ther. 126, 258 (1959).
Walaszek, E. J., Bunag, R. D., Huggins, C. G.: The characterization of the hypertensive polypeptide substance. J. Pharmacol, exp. Ther. 138, 139 (1962).
Waldhäusl, W., Kenner, TH.: Über die Entstehung einer nichtdialysierbaren vasopresso- rischen Aktivität der Erwärmung von Serum. Pharmacol. Exp. (Basel) 12, 388 (1965).
Weber, C. J., Major, R. H., Lobb, D.: The production of a pressor substance from serum globulin by action of pepsin. Science 96, 44 (1942).
Werle, E., Hochstrasser, K.: Versuche zur Isolierung eines niedermolekularen Kininogens. Hoppe-Seyler Z. physiol. Chem. 332, 322 (1963).
Werle, E., Hochstrasser, K., Trautschold, I.: Studies of bovine plasma, kininogen, ornitho-kallikrein and ornithokinin. Symposium on hypotensive peptides. Berlin-Heidel- berg-New York: Springer 1966.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1974 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Croxatto, H.R. (1974). Plasma of Serum Vasopressor Peptides Other than Angiotensins. In: Page, I.H., Bumpus, F.M. (eds) Angiotensin. Handbuch der experimentellen Pharmakologie / Handbook of Experimental Pharmacology, vol 37. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-65600-2_13
Download citation
DOI: https://doi.org/10.1007/978-3-642-65600-2_13
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-65602-6
Online ISBN: 978-3-642-65600-2
eBook Packages: Springer Book Archive